Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
Budget 2023
Budget 2023
you are here: HomeNewsTrendsHealth

Johnson & Johnson single-shot vaccine prevents COVID-19, but less than some others

With vaccinations off to a rocky start globally, experts had been counting on a one-dose vaccine that would stretch scarce supplies and avoid the logistics nightmare of getting people to return for boosters.

January 30, 2021 / 07:33 AM IST

Johnson & Johnson’s COVID-19 vaccine appears to protect against the novel coronavirus with just one shot. While it is not as effective as other two-shot rivals, it is still potentially helpful for a world in dire need of more vaccine doses.

J&J on January 29 said that in the US and seven other countries, the single-shot vaccine was 66% effective overall at preventing moderate to severe illness, and much more protective (85%) against the most serious symptoms.

There was some geographic variation. The vaccine worked better in the US — 72% effective against moderate to severe COVID-19 – compared to 57% in South Africa, where it was up against an easier-to-spread mutated virus.

Track this LIVE blog for all the latest updates on coronavirus pandemic